Showing results (111-120 of 270) with videos related to

Sort By:
Pageof 27
Journal for Immunotherapy of Cancer|July 2, 2024
Extensive-stage small-cell lung cancer in patients receiving atezolizumab plus carboplatin-etoposide: stratification of outcome based on a composite score that combines gene expression profiling and immune characterization of microenvironmentAnna Tosi, Martina Lorenzi, Paola Del Bianco, et al.
Breast (Edinburgh, Scotland)|October 27, 2017
External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experienceGaia Griguolo, William Jacot, Eva Kantelhardt, et al.
Frontiers in Oncology|January 5, 2026
Radiomic approach to support multidisciplinary tumor board decision-making in locally advanced non-small cell lung cancerGiulia Pasello, Harel Kotler, Alessandra Ferro, et al.
Journal of Neuro-Oncology|March 1, 2018
Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancerAmélie Darlix, Gaia Griguolo, Simon Thezenas, et al.
Frontiers in Immunology|February 7, 2024
Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysisLaura Bonanno, Lorenzo Calvetti, Alessandro Dal Maso, et al.
Annals of Surgical Oncology|February 9, 2011
Magnetic resonance imaging and ultrasonography in predicting infiltrating residual disease after preoperative chemotherapy in stage II-III breast cancerValentina Guarneri, Annarita Pecchi, Federico Piacentini, et al.
Clinical Breast Cancer|October 28, 2008
Multicentric, randomized phase III trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER2- positive breast cancer (Short-HER Trial; NCT00629278)Valentina Guarneri, Antonio Frassoldati, Paolo Bruzzi, et al.
Critical Reviews in Oncology/Hematology|August 17, 2025
Clinical insight on the pathway of SLFN11 as emergent biomarker in SCLCDaniela Scattolin, Frank W J Heijboer, Jules L Derks, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2024
HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndromeMichele Bottosso, Renata L Sandoval, Benjamin Verret, et al.
Journal of Clinical Pathology|June 21, 2023
PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2- BC patients with residual disease after neoadjuvant chemotherapy: a cohort studyFederica Miglietta, Valentina Carraro, Ottavia Amato, et al.
Pageof 27